News for the Multiple Sclerosis Community

FDA approves Novantrone

Last month, the FDA approved Novantrone(mitoxantrone) for patients with the secondary progressive form of MS. The FDA warned that some patients can develop serious heart problems. The drug us currently used to treat certain types of cancer.

The story can be found here at MSNBC.